LP

Lee's Pharmaceutical

China - Guangzhou
Pharmaceutical

Focus: Small Molecules

Lee's Pharmaceutical is a life sciences company focused on Small Molecules.

OncologyCardiovascularNeurologyUnknownNephrology
Funding Stage
PUBLIC
Open Jobs
3

Products & Portfolio (1)

Pipeline & Clinical Trials

FiberSense system
Healthy Subjects
N/A
Clinical Trials (1)
NCT03008044Evaluation of a Percutaneous Optical Fibre Glucose Sensor (FiberSense System)
N/A
continuous glucose-monitoring
Diabetes
N/A
Clinical Trials (1)
NCT04964752A Study of the Continuous Glucose Monitoring System for Home Use in Patients With Diabetes
N/A
Clinical Study Evaluating the Efficacy of Iron Proteinsuccinylate Oral Solution(FERPLEX) in Women Wi
Patients With Iron Deficiency Anemia in Gynecology
N/A
Clinical Trials (1)
NCT05192291Clinical Study Evaluating the Efficacy of Iron Proteinsuccinylate Oral Solution(FERPLEX) in Women With Gynecologic Iron Deficiency Anemia
N/A
FiberSense sensor
Diabetes Mellitus
N/A
Clinical Trials (1)
NCT03008239Effectiveness and Safety Study of the Percutaneous Optical Fibre Glucose Sensor (FiberSense)
N/A
N/A
Clinical Trials (1)
NCT03662958Comparison of a Novel Leuprolide With Market Leuprolide
N/A
Clinical Trials (1)
NCT02800447Procarbazine Hydrochloride Capsule (Natulan®) Clinical Trial Protocol
N/A
Inhaled nitric oxide
Pulmonary Hypertension
N/A
Clinical Trials (1)
NCT07099144Inhaled Nitric Oxide for the Treatment of Neonatal Hypoxic Respiratory Failure With Pulmonary Hypertension
N/A
Propionyl L-carnitine Hydrochloride
Peripheral Arterial Disease
Phase 1
Clinical Trials (1)
NCT02786069A Single-dose Escalation Safety and PK Study for PLC in Healthy Chinese
Phase 1
trazodone hydrochloride prolonged-release tablet
Depression
Phase 1
Clinical Trials (1)
NCT02785614PK Study of Multi-dose Trazodone Hydrochloride Prolonged-released Tablets in Healthy Chinese
Phase 1
Inhaled Fentanyl Aerosol
Cancer
Phase 1
Clinical Trials (1)
NCT06953453A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors
Phase 1
0.1% Pazufloxacin Mesilate Ear Drops
Otitis Media
Phase 1
Clinical Trials (1)
NCT02592096Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol
Phase 1
recombinant anti-PD-L1 monoclonal antibody injection combined with carboplatin and etoposide
Extensive Stage Small Cell Lung Cancer
Phase 1
Clinical Trials (1)
NCT04346914Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer
Phase 1
Phase 1
Clinical Trials (1)
NCT01588132Anfibatide Phase 1 Clinical Trial in Healthy Volunteers
Phase 1
Phase 1
Clinical Trials (1)
NCT04603846A Study of Anti-PD-L1 Antibody ZKAB001 Combined With Albumin-bound Paclitaxel in Advanced Urothelial Carcinoma
Phase 1
ZKAB001 5mg/kg
Biliary Tract Cancer
Phase 1
Clinical Trials (1)
NCT04608786A Clinical Study of PD-L1 Antibody ZKAB001 Combined With Capecitabine in Resected Biliary Tract Cancer
Phase 1
Propionyl-L-Carnitine Hydrochloride
Peripheral Arterial Diseases
Phase 1
Clinical Trials (1)
NCT02786043PK Study to Evaluate the Effect of PLC on Healthy Chinese Subjects by Multiple-doses
Phase 1
TG02 capsules oral administration, BIW in every 28d
High-grade Gliomas
Phase 1
Clinical Trials (1)
NCT03904628Phase I Clinical Study of Oral TG02 Capsule in the Treatment of Recurrent / Progressive High-grade Glioma Patients
Phase 1
Trazodone Hydrochloride prolonged-release tablets
Depression
Phase 1
Clinical Trials (1)
NCT02785601PK Study of Diet Effect of Trazodone Hydrochloride Prolonged-Released Tablets in Healthy Chinese
Phase 1
istaroxime
Healthy
Phase 1
Clinical Trials (1)
NCT02477449Istaroxime Infusion for 24 Hours in Chinese Healthy Volunteers
Phase 1
Pazufloxacin Mesilate ear drops
Chronic Suppurative Otitis Media
Phase 1
Clinical Trials (1)
NCT03675841Pazufloxacin Mesilate Ear Drops in Patients With Chronic Suppurative Otitis Media
Phase 1
Clinical Trials (1)
NCT06374485Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment
Phase 1
Clinical Trials (1)
NCT04627116An Ascending, Multiple-Dose, Safety and Tolerability Study of Tecarfarin in Healthy Chinese Volunteers
Phase 1
Gimatecan 0.6mg/m2/d
Ovarian Epithelial Cancer
Phase 1
Clinical Trials (1)
NCT04029909A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
Phase 1
Phase 1
Clinical Trials (1)
NCT03738111Study of TG02 Citrate in Patients With Advanced Hepatocellular Carcinoma
Phase 1
TAB014
AMD
Phase 1
Clinical Trials (1)
NCT03675880TAB014(Drug Code) in Wet( Neovascular)Age-related Macular Degeneration(AMD) Subjects
Phase 1
ZKAB001 5mg/kg
Cervical Cancer
Phase 1
Clinical Trials (1)
NCT03676959A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Recurrent or Metastatic Cervical Cancer
Phase 1
Clinical Trials (1)
NCT03652792Bioequivalence Study of Azilsartan Tablets in Chinese Healthy Volunteers
Phase 1
Clinical Trials (1)
NCT03652779A Study to Evaluate the Safety and Tolerability of Tecarfarin in Healthy Chinese Volunteers
Phase 1
20mg Azilsartan Tablets
Hypertension
Phase 1
Clinical Trials (1)
NCT02786082Pharmacokinetics Study of Azilsartan Tablets in Chinese Healthy Volunteers
Phase 1
Anfibatide 5 IU/60kg
Antiplatelet Drug
Phase 1
Clinical Trials (1)
NCT04404790Antiplatelet Thrombolysin (Anfibatide) Phase 1 Clinical Trial in Healthy Volunteers
Phase 1
Clinical Trials (1)
NCT01585259Anfibatide Phase Ib-IIa Clinical Trial
Phase 1/2
ZKAB001 5mg/kg
Osteosarcoma
Phase 1/2
Clinical Trials (1)
NCT03676985A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma
Phase 1/2
anti-PD-L1 antibody
Esophageal Cancer
Phase 1/2
Clinical Trials (1)
NCT04460066A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma.
Phase 1/2
Adapalene + Clindamycin Hydrochloride
Acne
Phase 1/2
Clinical Trials (1)
NCT02593383Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne
Phase 1/2
Inhaled fentanyl aerosol
Breakthrough Cancer Pain
Phase 1/2
Clinical Trials (1)
NCT04713189Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain
Phase 1/2
Clinical Trials (1)
NCT04849260Phase Ib/II Clinical Study of Pexa-Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Combined With Recombinant Whole Human Anti-PD-L1 Monoclonal Antibody (ZKAB001) in Metastatic Melanoma
Phase 1/2
ZKAB001 5mg/kg
Urothelial Carcinoma
Phase 1/2
Clinical Trials (1)
NCT03676946A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Locally Advanced and Metastatic Urothelial Carcinoma
Phase 1/2
Inhaled fentanyl aerosol
Breakthrough Cancer Pain
Phase 2
Clinical Trials (1)
NCT05531422Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP
Phase 2
Clinical Trials (1)
NCT04846842A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
Phase 2
Clinical Trials (1)
NCT02495012Anfibatide Treatment in STEMI Patients
Phase 2
Clinical Trials (1)
NCT01557179Evaluation of the Efficacy and Safety of Hyaluronic Acid Vaginal Gel to Ease Vaginal Dryness
Phase 2
Clinical Trials (1)
NCT04021173A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Phase 2
Recombinant Human Interferon a-2b Gel
HPV Infection
Phase 2
Clinical Trials (1)
NCT02593968Yallaferon in Chinese Population
Phase 2
Phase 2
Clinical Trials (1)
NCT04501029A Study of Gimatecan (ST1481) in Small Cell Lung Cancer
Phase 2
Phase 2
Clinical Trials (1)
NCT04571489A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer
Phase 2
Yallaferon®, the recombinant human interferon α-2b gel
Cervical HPV-16 and / or HPV-18 Infection
Phase 2/3
Clinical Trials (1)
NCT02801383Recombinant Human Interferon a-2b Gel for HPV-16 and/ or HPV-18 Gynecological Infections
Phase 2/3
Yallaferon®
HPV Infection
Phase 2/3
Clinical Trials (1)
NCT01824992Recombinant Human Interferon a-2b Gel for HPV Gynecological Infections
Phase 2/3
Trazodone
Depression
Phase 2/3
Clinical Trials (1)
NCT01524497A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression
Phase 2/3
Levocarnitine Injection
Heart Failure,
Phase 2/3
Clinical Trials (1)
NCT01580553The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure
Phase 2/3
Phase 3
Clinical Trials (1)
NCT04982692A Clinical Study of INTRAROSA® (Prasterone) Vaginal Inserts in Postmenopausal Vulvovaginal Atrophy
Phase 3

Open Jobs (3)

Interview Prep Quick Facts
Portfolio: 1 approved product, 73 clinical trials
Top TAs: Oncology, Cardiovascular, Neurology
Publications: 25 in PubMed
Open Roles: 3 active jobs
Portfolio Health
Peak1 (100%)
1 total products
Therapeutic Area Focus
Oncology
23 pipeline
Cardiovascular
8 pipeline
Neurology
5 pipeline
Nephrology
2 pipeline
Respiratory
2 pipeline
Hematology
1 pipeline
Marketed
Pipeline